S&P 500 (NYSE:SPY) component Humana, Inc. (NYSE:HUM) will unveil its latest earnings on Monday, February 6, 2012. Humana is a managed health care company that offers health and supplemental benefit products.
Humana, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of $1.20 per share, a decline of 27.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $1.18. Between one and three months ago, the average estimate moved up. It has risen from $1.19 during the last month. For the year, analysts are projecting net income of $8.44 per share, a rise of 17.5% from last year.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 52 cents, reporting profit of $2.54 per share against a mean estimate of net income of $2.02 per share.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a rise of 10.7% in revenue from the year-earlier quarter to $9.24 billion.
Analyst Ratings: Analysts are bullish on this stock with 13 analysts rating it as a buy, none rating it as a sell and 10 rating it as a hold.
A Look Back: In the third quarter, profit rose 13.1% to $444.8 million ($2.67 a share) from $393.2 million ($2.32 a share) the year earlier, exceeding analyst expectations. Revenue rose 10.4% to $9.3 billion from $8.42 billion.
The company has seen net income rise in three straight quarters. Net income rose 35.3% in the second quarter and 21.8% in the first quarter.
Revenue has risen the past four quarters. Revenue rose 7.3% in the second quarter from the year earlier, climbed 8.9% in the first quarter from the year-ago quarter and 9.4% in the fourth quarter of the last fiscal year.
Stock Price Performance: During November 2, 2011 to January 31, 2012, the stock price had risen $3.34 (3.9%) from $85.68 to $89.02. The stock price saw one of its best stretches over the last year between December 30, 2011 and January 11, 2012 when shares rose for eight-straight days, rising 7.9% (+$6.91) over that span. It saw one of its worst periods between January 19, 2012 and January 26, 2012 when shares fell for six-straight days, falling 8.2% (-$7.83) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Earnings Preview Stories:
To contact the reporter on this story: Derek Hoffman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org